StrainX Bioworks Raises $13M to Scale Precision Fermentation Platform in India
Indian startup StrainX Bioworks has raised $13 million to expand its precision fermentation platform for nutritional and flavor ingredients as it moves toward commercial production.
AI颠覆作物保护研发范式丨拜耳CropKey创始人亲临CPEW 2026解析研发革命
人工智能正在重写农药研发的底层逻辑——不是优化现有流程,而是从根本上改变"如何发现下一个有效分子"这个问题本身。这套方法的创造者,将亲自来到CPEW 2026的现场。
Adcendo inks MSD supply deal to run ADC-Keytruda combination study
Copenhagen-based Adcendo plans to start a Phase Ib trial of the combination in the second half of the year. Participants will receive ADCE-T02, Adcendo’s tissue factor (TF)-directed ADC, with the anti-PD-1 checkpoint inhibitor Keytruda. Adcendo, which will sponsor the trial, began a Phase I monotherapy trial of ADCE-T02 in 2024.
Zoomlion opens Latin America hub
The new center integrates product display, technical training, after-sales support, maintenance services, and customer experience, aiming to build a comprehensive service platform covering the entire Latin American market. As a key strategic hub for the region, it will showcase agricultural equipment and a complete spare parts system while providing localized and professional lifecycle support services.
Strait of Hormuz: Time Running out to Avert Global Food Security Crisis, FAO Warns
May 2026, Rome: The actions taken now will be critical in determining whether the world can manage the shock caused by t…
Three in One Go: LimmaTech, Curevo, Vaccine Company
With these three acquisitions, Eli Lilly and Company is significantly expanding its infectious disease activities. From a European perspective, the centrepiece is clearly the acquisition of LimmaTech Biologics in Schlieren near Zurich. Lilly will pay up to US$780 million for the clinical-stage vaccine company, including milestone-based payments.
Triple Play: Lilly Acquires Three Developers of Infectious Disease Vaccines for Up-to-$3.8B
Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up to $3.83 billion cash, the companies said today, in deals intended to expand the acquisitive pharma giant’s R&D efforts into infectious disease—and which represent Lilly’s eighth, ninth, and 10th planned buyouts of smaller biotechs this year alone.
StrainX Bioworks nets $13m to scale biomanufacturing platform: ‘India is going to be the fermentation capital of the world’
Indian startup StrainX Bioworks has raised $13 million to scale a precision fermentation platform producing high-value n…
Making impact tire pressure visible
A series of live, side-by-side demonstrations showed how tire pressure and construction affect traction, slippage, soil behavior and overall operational efficiency. Similar demonstration formats in other European markets have already highlighted how strongly tire setup can influence efficiency. At a recently held Alliance Field Day in the UK, controlled comparisons showed fuel consumption differences of up to 20% depending on tire pressure and configuration. Building on this approach, the Sicily event focused on making these effects visible under local field conditions. The day was designed to make one thing clear: what happens in the soil when tire setup changes.
Guest article: Building the next generation of the global meat trade as a sovereign mandate
Editor’s note: Ahmed Bin Sulayem is the executive chairman and CEO of Dubai Multi Commodities Centre (DMCC). The v…
